Delivery Order SPE2DB20D3101-SPE2DB23FQTM9
Award Date 10/31/22
Potential Completion Date 11/1/22
Potential Value $8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566347680 ROPIVACAINE 0.2% 200 MG/100 ML 100ML. The single-award contract has a firm fixed price of $1,046.28 and an ultimate completion date of November 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This federal contract award, worth $3,217.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of 4565732573 - ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a specialty medication, to support military treatment facilities and other government healthcare programs. The contract has an ultimate completion date of September 10, 2024 and is a Firm Fixed Price Delivery Order. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,883.24 firm-fixed-price delivery order is for the supply of 4565878585 - Ropivacaine 0.2% 400 mg/200 ml medication. The contract has a period of performance through September 20, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4566333296 - Ropivacaine 0.2% 400 mg/200 ml 200 ml. The contract has a ceiling value of $1,335.38 and is a firm-fixed price delivery order that runs through November 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,526.20 firm fixed-price delivery order is for the supply of 200 mg/100 mL vials of the medication ropivacaine 0.2%. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557598550 - Ropivacaine 0.2% 400 mg/200 ml 200 ml. The firm-fixed-price delivery order, valued at $1,382.37, was awarded on June 21, 2022 with a completion date of June 22, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit...
- This federal contract award, identified as SPE2DB20D1109|SPE2DB25FN95V, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropivacaine 0.2% 400 mg/200 ml, a pharmaceutical product, with a ceiling value of $3,605.54 and a performance period through April 28, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, for the delivery of 4564014130 - Ropivacaine 0.2% 400 mg/200 ml, a specialty brand name medication. The award, valued at $7,621.52, is a firm fixed price delivery order with a completion date of March 20, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,832.75 firm fixed price delivery order is for 4566601078 ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a specialty medication, with a performance period through December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,491.09 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml units. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, following the award date of January 6, 2026. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's...